FDA grants priority review to AstraZeneca’s Imfinzi combination for bladder cancer AstraZeneca (AZN) announced that the U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental Biologics License Application for Imfinzi (durvalumab)...
That could cost you big, Acadia Pharmaceuticals stock tumbles on mixed trial results Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 6% after the company announced Phase 2 results from its RADIANT study of remlifanserin for the treatment of Alzheimer’s disease...
Hole in one, Newton Golf acquires option on Nevada beryllium-tungsten mine Newton Golf Company, Inc. (NWTG), a golf equipment maker, has acquired an option to purchase the Pole Canyon beryllium-tungsten project in White Pine County, Nevada, marking the company’s entry...
This is just a phase, Celldex stock rises after positive phase 3 trial results Celldex Therapeutics (NASDAQ: CLDX) shares rose 8% Tuesday after the company announced positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in...
Let’s make a deal, American Resources unit signs LOI to acquire Blackion in all-stock deal American Resources Corporation (AREC) announced that its majority-owned subsidiary, Electrified Materials Corporation (EMCO), has signed a binding Letter of Intent to acquire...
Lights, camera, acquisition; National CineMedia completes $275M acquisition of Captivate National CineMedia, Inc. (NCMI) completed its acquisition of Captivate Holdings, LLC on September 18, 2026, for an enterprise value of $275.0 million, according to a press release...
